Growth Metrics

Arcturus Therapeutics Holdings (ARCT) Non-Current Assets: 2018-2025

Historic Non-Current Assets for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $33.1 million.

  • Arcturus Therapeutics Holdings' Non-Current Assets fell 16.80% to $33.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year decrease of 16.80%. This contributed to the annual value of $38.1 million for FY2024, which is 11.03% down from last year.
  • As of Q3 2025, Arcturus Therapeutics Holdings' Non-Current Assets stood at $33.1 million, which was down 4.67% from $34.8 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Non-Current Assets ranged from a high of $64.4 million in Q3 2023 and a low of $10.8 million during Q2 2021.
  • Moreover, its 3-year median value for Non-Current Assets was $42.8 million (2023), whereas its average is $43.9 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Non-Current Assets surged by 322.36% in 2022 and then crashed by 38.13% in 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Non-Current Assets (Quarterly) stood at $13.9 million in 2021, then surged by 239.67% to $47.1 million in 2022, then dropped by 9.02% to $42.8 million in 2023, then dropped by 11.03% to $38.1 million in 2024, then decreased by 16.80% to $33.1 million in 2025.
  • Its Non-Current Assets was $33.1 million in Q3 2025, compared to $34.8 million in Q2 2025 and $53.0 million in Q1 2025.